中文名稱:PFN62958 | 英文名稱:PFN62958 |
CAS:2230662-95-8 | 品牌: TanzhenBio |
產(chǎn)地: 江西 | 保存條件: 4℃ |
純度規(guī)格: 98% | 產(chǎn)品類別: 放射顯影多肽產(chǎn)品 |
是否進口: 否 |
PFN62958 is a useful peptide linker for synthesis of PSMA-617 (vipivotide tetraxetan), which is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA-617 originally was developed at the German Cancer Research Center and the Heidelberg University Hospital. ABX held the exclusive license to bring the treatment, which targets prostate-specific membrane antigen (PSMA), through early clinical development. is a tris(tert-butyl)-protected JUN68744 derivative.
PFN62958
Furin Substrate
Polymyxin B nonapeptide TFA
MC-Gly-Gly-Gly-PAB
MC-GGFG-PAB
MC-Gly-Gly-Phe-Gly-PAB-PNP
otbu-Glu(otbu)-urea-Lys(Ahx)
成立日期 | 2019-02-05 (6年) | 注冊資本 | 300萬人民幣 |
員工人數(shù) | 10-50人 | 年營業(yè)額 | ¥ 100萬-300萬 |
主營行業(yè) | 生物活性小分子,有機合成試劑,氨基糖苷類 | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |